Dong J - Search Results

1

Donor germ-line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes.

Auer PL, Farazi M, Zhang T, Dong J, Bolon YT, Spellman SR, Saber W. Auer PL, et al. Among authors: dong j. Am J Hematol. 2024 Apr;99(4):770-773. doi: 10.1002/ajh.27243. Epub 2024 Feb 9. Am J Hematol. 2024. PMID: 38339773

2

Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation.

Dong J, Buradagunta CS, Zhang T, Spellman S, Bolon YT, DeZern AE, Gadalla SM, Deeg HJ, Nazha A, Cutler C, Cheng C, Urrutia R, Auer P, Saber W. Dong J, et al. J Hematol Oncol. 2023 Mar 10;16(1):21. doi: 10.1186/s13045-023-01418-4. J Hematol Oncol. 2023. PMID: 36899395 Free PMC article.

3

Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study.

Zhang T, Auer P, Dong J, Cutler C, Dezern AE, Gadalla SM, Deeg HJ, Nazha A, Carlson KS, Spellman S, Bolon YT, Saber W. Zhang T, et al. Among authors: dong j. J Hematol Oncol. 2023 Apr 11;16(1):37. doi: 10.1186/s13045-023-01431-7. J Hematol Oncol. 2023. PMID: 37041565 Free PMC article.

4

Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance.

Buradagunta CS, Arsang-Jang S, Massat B, Thapa B, Patek V, D'Souza A, Auer P, Urrutia R, Janz S, Dhakal B, Hari P, Dong J. Buradagunta CS, et al. Among authors: dong j. Leukemia. 2024 Feb;38(2):383-385. doi: 10.1038/s41375-023-02078-6. Epub 2023 Nov 2. Leukemia. 2024. PMID: 37919604 No abstract available.

5

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation.

Guru Murthy GS, Zhang T, Bolon YT, Spellman S, Dong J, Auer P, Saber W. Guru Murthy GS, et al. Among authors: dong j. Biomark Res. 2024 Jan 25;12(1):10. doi: 10.1186/s40364-023-00550-0. Biomark Res. 2024. PMID: 38273355 Free PMC article.

6

Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.

Li JR, Arsang-Jang S, Cheng Y, Sun F, D'Souza A, Dhakal B, Hari P, Huang Q, Auer P, Li Y, Urrutia R, Zhan F, Shaughnessy JD Jr, Janz S, Dong J, Cheng C. Li JR, et al. Among authors: dong j. Blood Cancer J. 2024 Mar 6;14(1):38. doi: 10.1038/s41408-024-01024-8. Blood Cancer J. 2024. PMID: 38443358 Free PMC article.

7

Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.

Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B. Hammons L, et al. Among authors: dong j. Br J Haematol. 2024 Mar;204(3):887-891. doi: 10.1111/bjh.19244. Epub 2023 Dec 6. Br J Haematol. 2024. PMID: 38054558

8

WDR26 and MTF2 are therapeutic targets in multiple myeloma.

Sun F, Cheng Y, Riordan JD, Dupuy A, Dubois W, Pisano M, Dong J, Mock B, Zhan F, Hari P, Janz S. Sun F, et al. Among authors: dong j. J Hematol Oncol. 2021 Dec 7;14(1):203. doi: 10.1186/s13045-021-01217-9. J Hematol Oncol. 2021. PMID: 34876184 Free PMC article.

9

Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.

Mohan M, Janz S, Brazauskas R, Dwinell MB, Teng BQ, Yun G, Dong J, Pasquini MC, Giralt S, Landau H, Stadtmauer E, Krishnan A, D'Souza A. Mohan M, et al. Among authors: dong j. Bone Marrow Transplant. 2023 Aug;58(8):953-955. doi: 10.1038/s41409-023-02004-5. Epub 2023 May 6. Bone Marrow Transplant. 2023. PMID: 37149674 Free PMC article. No abstract available.

10

Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.

Dong J, Garacci Z, Buradagunta CS, D'Souza A, Mohan M, Cunningham A, Janz S, Dhakal B, Thrift AP, Hari P. Dong J, et al. Blood Cancer J. 2022 Feb 24;12(2):34. doi: 10.1038/s41408-022-00633-5. Blood Cancer J. 2022. PMID: 35210395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,088 results

Search Page